Bumex and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumex (bumetanide) and Adalat (nifedipine). Common drug interactions include blood pressure decreased among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Bumex and Adalat. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Bumex?

Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

On Jul, 06, 2026

32 people who take Bumex and Adalat together, and have interactions are studied.

What are the common drug interactions of Bumex and Adalat, by gender? *:

female:

Blood pressure decreased
Body temperature decreased
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiovascular disorder (heart diseases)
Congestive (dilated) cardiomyopathy (weakening of dilated heart muscle)
Constipation
Crepitations (noises are produced by the rubbing of parts one against the other)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dizziness

male:

Pain
Burning sensation
Pain in extremity
Scar
Skin disorder (skin disease)
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness
Ocular icterus (presence of jaundice seen in the sclera of the eye)

What are the common drug interactions of Bumex and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Haemolytic uraemic syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more)
Urticaria (rash of round, red welts on the skin that itch intensely)
Vomiting

50-59:

Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Pain
Pain in extremity
Scar
Skin disorder (skin disease)
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Skin tightness

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Renal failure (kidney dysfunction)
Oedema peripheral (superficial swelling)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Sepsis (a severe blood infection that can lead to organ failure and death)
Stupor (lack of critical cognitive function and level of consciousness)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Vomiting
Dyspnoea (difficult or laboured respiration)
Bradycardia (abnormally slow heart action)

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 5 people, 15.62%
Pain: 4 people, 12.50%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 9.38%
Chest Pain: 3 people, 9.38%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 9.38%
Cough: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Bumex and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously